Zhang Rui-tao, Shi Hui-rong, Huang Hao-liang, Chen Zhi-min, Liu Hui-na, Yuan Zhong-fu
Department of Obstetrics and Gynecology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Nan Fang Yi Ke Da Xue Xue Bao. 2011 Sep;31(9):1551-5.
To investigate the expressions of metastasis-associated in colon cancer-1 (MACC1), hepatocyte growth factor (HGF), and C-met proteins in epithelial ovarian cancer and their significance.
The expressions of MACC1, HGF and C-met in 20 specimens of normal ovarian tissues, 19 specimens of benign epithelial ovarian tumor and 52 specimens of epithelial ovarian cancer were measured by immunohistochemistry and Western blotting. The correlations of the expressions of MACC1, HGF and C-met protein to the clinicopathologic characteristics of epithelial ovarian cancer were analyzed, and the correlations between the expressions of the 3 proteins were also evaluated.
The positivity rates of MACC1, HGF and C-met proteins were 73.1%, 63.5% and 78.8% in epithelial ovarian cancer with relative expressions of 0.72∓0.05, 0.64∓0.04 and 0.79∓0.04, respectively, showing significant differences from those in normal ovarian tissues and benign ovarian tumors (P<0.05). In epithelial ovarian cancer, the up-regulation of MACC1, HGF and C-met expressions were associated with advanced FIGO stage, poor differentiation and lymph node metastasis (P<0.05). MACC1 expression was positively correlated to HGF (r=0.350, P=0.011) and C-met expressions (r=0.429, P=0.002), and the latter two was also positively correlated (r=0.487, P=0.000).
MACC1 may serve as a potential biomarker for advanced ovarian cancer. Deregulation of MACC1, HGF and C-met proteins may synergistically participate in the malignant progression of epithelial ovarian cancer.
探讨结肠癌转移相关蛋白1(MACC1)、肝细胞生长因子(HGF)及C- 甲蛋白(C-met)在上皮性卵巢癌中的表达及其意义。
采用免疫组织化学和蛋白质印迹法检测20例正常卵巢组织、19例良性上皮性卵巢肿瘤及52例上皮性卵巢癌组织中MACC1、HGF及C-met的表达。分析MACC1、HGF及C-met蛋白表达与上皮性卵巢癌临床病理特征的相关性,并评估这3种蛋白表达之间的相关性。
上皮性卵巢癌中MACC1、HGF及C-met蛋白阳性率分别为73.1%、63.5%和78.8%,相对表达量分别为0.72±0.05、0.64±0.04和0.79±0.04,与正常卵巢组织及良性卵巢肿瘤相比差异有统计学意义(P<0.05)。在上皮性卵巢癌中,MACC1、HGF及C-met表达上调与国际妇产科联盟(FIGO)分期晚、分化差及淋巴结转移相关(P<0.05)。MACC1表达与HGF(r=0.350,P=0.011)及C-met表达(r=0.429,P=0.002)呈正相关,后两者之间也呈正相关(r=0.487,P=0.000)。
MACC1可能是晚期卵巢癌的潜在生物标志物。MACC1、HGF及C-met蛋白的失调可能协同参与上皮性卵巢癌的恶性进展。